{"transactions":[{"id":804520,"issuer":{"id":4435,"kind":"organization","name":"Kailera Therapeutics, Inc.","symbol":"KLRA"},"owners":[{"id":51946,"kind":"person","name":"Kaplan Andrew T.","position":1,"cik":"0001752059","reported_name":"Kaplan Andrew T.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-04-20T22:00:25.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":38300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest and become exercisable as to 100% of the underlying shares on April 16, 2027, subject to Mr. Kaplan's continued service through each such vesting date."}],"balance_after":38300,"derivative":{"exercise_price":16,"expiration_date":"2036-04-16","underlying":"Common Stock","underlying_shares":38300},"source":{"system":"sec-edgar","filing":"0001193125-26-164388","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1752059/000119312526164388/ownership.xml","form_type":"4"}},{"id":804519,"issuer":{"id":4435,"kind":"organization","name":"Kailera Therapeutics, Inc.","symbol":"KLRA"},"owners":[{"id":51946,"kind":"person","name":"Kaplan Andrew T.","position":1,"cik":"0001752059","reported_name":"Kaplan Andrew T.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-04-20T22:00:25.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":false,"shares":17857143,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1:1 basis upon the closing of the Issuer's initial public offering. These securities had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1:1 basis upon the closing of the Issuer's initial public offering. These securities had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1:1 basis upon the closing of the Issuer's initial public offering. These securities had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by BCPE Perseus Investor, LP (\"BCPE Perseus\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Kaplan is a Partner of Bain Capital Investors, LLC (\"BCI\"). BCI is the ultimate general partner of BCPE Perseus. As a result, Mr. Kaplan may be deemed to share voting and dispositive power with respect to the securities held by BCPE Perseus. Mr. Kaplan disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17857143},"source":{"system":"sec-edgar","filing":"0001193125-26-164388","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1752059/000119312526164388/ownership.xml","form_type":"4"}},{"id":804518,"issuer":{"id":4435,"kind":"organization","name":"Kailera Therapeutics, Inc.","symbol":"KLRA"},"owners":[{"id":51946,"kind":"person","name":"Kaplan Andrew T.","position":1,"cik":"0001752059","reported_name":"Kaplan Andrew T.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-20T22:00:25.000Z","date":"2026-04-20","kind":"purchase","planned":false,"acquired":true,"shares":8398438,"price":16,"value":134375008.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by BCPE Perseus Investor, LP (\"BCPE Perseus\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Kaplan is a Partner of Bain Capital Investors, LLC (\"BCI\"). BCI is the ultimate general partner of BCPE Perseus. As a result, Mr. Kaplan may be deemed to share voting and dispositive power with respect to the securities held by BCPE Perseus. Mr. Kaplan disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":26255581,"source":{"system":"sec-edgar","filing":"0001193125-26-164388","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752059/000119312526164388/ownership.xml","form_type":"4"}},{"id":804517,"issuer":{"id":4435,"kind":"organization","name":"Kailera Therapeutics, Inc.","symbol":"KLRA"},"owners":[{"id":51946,"kind":"person","name":"Kaplan Andrew T.","position":1,"cik":"0001752059","reported_name":"Kaplan Andrew T.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-04-20T22:00:25.000Z","date":"2026-04-20","kind":"exercise","planned":false,"acquired":true,"shares":17857143,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of the Issuer's Series B Preferred Stock automatically converted into shares of the Issuer's Common Stock on a 1:1 basis upon the closing of the Issuer's initial public offering. These securities had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held directly by BCPE Perseus Investor, LP (\"BCPE Perseus\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Mr. Kaplan is a Partner of Bain Capital Investors, LLC (\"BCI\"). BCI is the ultimate general partner of BCPE Perseus. As a result, Mr. Kaplan may be deemed to share voting and dispositive power with respect to the securities held by BCPE Perseus. Mr. Kaplan disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein."}],"balance_after":17857143,"source":{"system":"sec-edgar","filing":"0001193125-26-164388","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752059/000119312526164388/ownership.xml","form_type":"4"}},{"id":1702254,"issuer":{"id":4534,"kind":"organization","name":"Surgery Partners, Inc."},"owners":[{"id":51946,"kind":"person","name":"Kaplan Andrew T.","position":1,"cik":"0001752059","reported_name":"Kaplan Andrew T.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-22T01:29:30.000Z","date":"2023-12-19","kind":"other","planned":false,"acquired":false,"shares":474407,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On December 19, 2023, BCPE Seminole distributed 474,407 shares of Common Stock to one or more members or partners in connection with certain charitable gifts made by such members or partners or their direct or indirect owners."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares of Common Stock held directly by BCPE Seminole Holdings LP (\"BCPE Seminole\"), BCPE Seminole Holdings II Intermediate LP (\"BCPE Seminole II\"), BCPE Seminole Holdings III, L.P. (\"BCPE Seminole III\") and BCPE Seminole Holdings IV, L.P. (\"BCPE Seminole IV\" and, together with BCPE Seminole, BCPE Seminole II and BCPE Seminole III, the \"Bain Capital Entities\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bain Capital Investors, LLC (\"BCI\") is the sole member of (i) BCPE Seminole GP LLC, which is the general partner of BCPE Seminole and BCPE Seminole IV, (ii) BCPE Seminole GP II LLC, which is the general partner of BCPE Seminole II, and (iii) BCPE Seminole GP III LLC, which is the general partner of BCPE Seminole III. Mr. Kaplan is a Partner of BCI. By virtue of the relationships described in these footnotes, Mr. Kaplan may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by the Bain Capital Entities. Mr. Kaplan disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":49946972,"source":{"system":"sec-edgar","filing":"0000950170-23-072382","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752059/000095017023072382/ownership.xml","form_type":"4"}},{"id":1702253,"issuer":{"id":4534,"kind":"organization","name":"Surgery Partners, Inc."},"owners":[{"id":51946,"kind":"person","name":"Kaplan Andrew T.","position":1,"cik":"0001752059","reported_name":"Kaplan Andrew T.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-12-22T01:29:30.000Z","date":"2023-12-19","kind":"sale","planned":false,"acquired":false,"shares":7826870,"price":33.44,"value":261730532.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents shares of Common Stock held directly by BCPE Seminole Holdings LP (\"BCPE Seminole\"), BCPE Seminole Holdings II Intermediate LP (\"BCPE Seminole II\"), BCPE Seminole Holdings III, L.P. (\"BCPE Seminole III\") and BCPE Seminole Holdings IV, L.P. (\"BCPE Seminole IV\" and, together with BCPE Seminole, BCPE Seminole II and BCPE Seminole III, the \"Bain Capital Entities\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Bain Capital Investors, LLC (\"BCI\") is the sole member of (i) BCPE Seminole GP LLC, which is the general partner of BCPE Seminole and BCPE Seminole IV, (ii) BCPE Seminole GP II LLC, which is the general partner of BCPE Seminole II, and (iii) BCPE Seminole GP III LLC, which is the general partner of BCPE Seminole III. Mr. Kaplan is a Partner of BCI. By virtue of the relationships described in these footnotes, Mr. Kaplan may be deemed to share voting and dispositive power with respect to the shares of Common Stock held by the Bain Capital Entities. Mr. Kaplan disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein."}],"balance_after":50421379,"source":{"system":"sec-edgar","filing":"0000950170-23-072382","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752059/000095017023072382/ownership.xml","form_type":"4"}}]}